Please note: Not all treatments are available in all countries. Advanced Accelerator Applications (NASDAQ:AAAP), a Novartis company, is an innovative radiopharmaceutical company developing, producing and commercializing molecular nuclear medicine theragnostics. Visit Advanced Accelerator Applications to learn about our radiopharmaceutical products. Arrangements will be been made by Advanced Accelerator Applications to resupply hospital sites with unaffected products. Below is a list of the treatments we currently offer via our US and International units. The remaining stock of the above batches should be quarantined and returned to the company directly. This recall is being issued as a company-led medicines recall, as this product is only supplied to several hospitals/customers and the manufacturer has full traceability. Brief description of the problemĪn Out-of-Specification (OOS) result was obtained during a stability study. NetSpot offers more than 15 heatmap visualizations that help troubleshoot and manage any Wi-Fi setup. Herzlich willkommen auf unserem YouTube Kanal Hier findet ihr Informationen und Neuigkeiten rund um das Thema Gesundheit. **Following correction by Advanced Accelerator Applications, an update was made on 22 March 2022 to reflect correction of the expiry date. NETSPOT (Kit for the preparation of gallium Ga 68 dotatate injection) Batch NumberĪctive Pharmaceutical Ingredient: 40mcg dotatate Browse our portfolio of therapeutic radiopharmaceuticals and nuclear medicine products for use in oncology, neurology, cardiology and other indications. Advanced Accelerator Applications Product description NETSPOT is a new FDA approved agent, gallium-68 dotatate, used as a Positron Emission Tomography (PET) tracer instead of radiolabeled glucose to better diagnose.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |